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Abstract
At any time, each cell of the protozoan parasite Trypanosoma brucei expresses a single species of its major antigenic protein,
the variant surface glycoprotein (VSG), from a repertoire of .2,000 VSG genes and pseudogenes. The potential to express
different VSGs by transcription and recombination allows the parasite to escape the antibody-mediated host immune
response, a mechanism known as antigenic variation. The active VSG is transcribed from a sub-telomeric polycistronic unit
called the expression site (ES), whose promoter is 40–60 kb upstream of the VSG. While the mechanisms that initiate
recombination remain unclear, the resolution phase of these reactions results in the recombinational replacement of the
expressed VSG with a donor from one of three distinct chromosomal locations; sub-telomeric loci on the 11 essential
chromosomes, on minichromosomes, or at telomere-distal loci. Depending on the type of recombinational replacement
(single or double crossover, duplicative gene conversion, etc), several DNA-repair pathways have been thought to play a
role. Here we show that VSG recombination relies on at least two distinct DNA-repair pathways, one of which requires RMI1-
TOPO3a to suppress recombination and one that is dependent on RAD51 and RMI1. These genetic interactions suggest that
both RAD51-dependent and RAD51-independent recombination pathways operate in antigenic switching and that
trypanosomes differentially utilize recombination factors for VSG switching, depending on currently unknown parameters
within the ES.
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Introduction
Monoallelic expression of multigene families occurs in a variety of
cellular processes, including mating-type switching in yeasts,
immunoglobulin gene diversification in B-cell development, odorant
receptors, and surface antigen variation in several pathogens [1-7].
Trypanosoma brucei is a protozoan pathogen that causes African
sleeping sickness. Only one allele of the variant surface glycoprotein
(VSG) isexpressed ata timeineachtrypanosome, yet thegenomemay
contain more than 2,000 VSG genes and pseudogenes. About 15 sub-
telomeric polycistronic expression sites (ES) contain a VSG , 50 kb
downstream oftheirpromoters [8-10] and about1 kb upstream ofthe
telomeric repeat array. Only one ES can transcribe a VSG at any time
and the rest are transcriptionally silent. Most VSGs are not associated
with an ES (minichromosomal and ‘telomere-distal’, also referred to
as ‘chromosome-internal’), and they lack promoters. Antigenic
switching is caused mainly by switching the expressed VSG through
DNA recombination. Infrequently, a new VSG can be activated by
switching the transcriptional status among the active and silent ES
(reviewed in [4,11,12]). Recombination-mediated VSG switching
occurs preferentially by gene conversion (GC) rather than crossover
[13-16], despite the fact that there are no clear advantages in
switching through GC in vivo.
One of the major factors that control mitotic crossover is the
RTR complex (also known as the BTB complex). This complex
consists of a RecQ-family helicase (BLM in mammals and SGS1
in budding yeast), a Topoisomerase III a, and RMI1/2 (BLAP75/
18 in mammals and RMI1 in budding yeast). RMI is the third
component that has been recently identified in several organisms
[17-23]. The functions of the RTR complex have been
documented extensively in yeasts and mammalian systems
[21,22,24-31]. The complex safeguards genome integrity by
influencing various aspects, including DNA replication, mitotic
and meiotic recombination, and telomere dynamics. One of major
functions of the RTR complex is to remove recombination
intermediates that may accumulate during these processes.
Genetic studies from budding yeast showed that the growth defect
of top3 is caused by the accumulation of recombination
intermediates and the defect could be relieved by mutations in
SGS1 or in the RAD51-pathway [28,32,33]. Recombination
intermediates accumulated when TOP3 enzyme activity was
compromised [34]. A Holliday Junction (HJ) is structurally similar
to a recombination intermediate, and the RTR complex is
required for the removal of both structures. In vitro studies showed
that human RMI1 (hRMI1) stimulates the double Holliday
Junction (dHJ) dissolution activity of TOPO3a and the dHJ
unwinding activity of BLM-TOPO3a [35,36]. In yeast, RMI1
stimulates the ssDNA binding and relaxation activity of TOP3 in
vitro [37]. hRMI1 interaction with TOPO3a appears to control
TOPO3a enzyme activity, as hRMI1 mutants defective for
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25313interaction with TOPO3a, not for DNA, lose the ability to
stimulate the dHJ dissolution activity of TOPO3a in vitro [38].
We showed previously that trypanosomes lacking TOPO3a
significantly increased VSG switching and this increase was largely
due to the elevated levels of VSG GC and VSG crossover [39]. The
data suggested that the RTR complex is probably conserved in T.
brucei and may play roles in VSG switching by controlling
undesirable recombination intermediates arising between the
active VSG and silent VSG donors. Here we identify the T. brucei
RMI1 homologue and demonstrate that TbRMI1 interacts with
TbTOPO3a and promotes productive VSG switching. We show
that, similarly to the previously described TOPO3a defect, RMI1
deficiency increases VSG switching rate by promoting VSG gene
conversion and crossover. Genetic interactions between TbRMI1
and TbRAD51 further reveal that antigenic variation is under
control of multiple recombination pathways, depending on where
the recombination occurs, and that VSG GC and ES GC are likely
to be initiated by different triggers.
Results
Deletion of Tb927.3.1830, a T. brucei DUF1767
domain-containing protein, causes a growth defect
We demonstrated previously that T. brucei TOPO3a plays
critical roles in recombination-mediated VSG switching [39].
RMI1 homologues that work together with TOPO3a-BLM
Figure 1. Deletion of Tb927.3.1830 causes a growth defect. (A) Alignment of Tb927.3.1830 with human, mouse and chicken RMI1. DUF1767
and OB-fold domains are indicated in pink and yellow boxes, respectively. Conserved lysine residues are in green box in the OB1 domain. Blue bars
show locations of five b-strands of OB1. (B) Deletion scheme for Tb927.3.1830. The entire open reading frames (ORFs) of Tb927.3.1830 were
sequentially deleted using cassettes containing HYG-TK or PUR flanked by loxP sites. The markers were removed by transient expression of Cre-
recombinase [39,64]. (C) Tbrmi1 exhibits a minor growth defect, similar to Tbtopo3a. Wild-type, rmi1
-/+ and rmi1
-/- cells were diluted to 10,000 cells/ml
and cells were counted after two days of incubation. This was repeated twice. Growth phenotypes of Tbtopo3a mutants were taken from the previous
study [39]. Error bars are shown, but are small. (D) Diagrams of human RMI1/2 [41] and Tb927.3.1830.
doi:10.1371/journal.pone.0025313.g001
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several model organisms [18-20,23,30]. RMI1 homologues share a
signature domain at the N-terminus, called DUF1767, whose
function is unknown. By BLAST searches, we found two T. brucei
proteins that contain a DUF1767 domain at the N-terminus,
Tb927.3.1830 and Tb927.8.2040.
Figure 1A shows sequence alignment of Tb927.3.1830 with
human, mouse, and chicken RMI1 homologues. RMI1 proteins
possess an ‘oligonucleotide and oligosaccharide binding’ (OB)-
fold (yellow box) next to the DUF1767 domain (pink box). In
higher eukaryotes, RMI1 contains another OB-fold domain
(OB2) in the C-terminus and associates with RMI2 (BLAP18) via
the interaction between OB2 of RMI1 and OB3 of RMI2
[21,22]. RMI1 deletion mimics TOP3 or TOPO3a deficiency in
other organisms. Yeast rmi1 mutant showed growth defects,
similar to top3 mutants [19,23]. Tbtopo3a exhibited a minor
growth defect [39]. To determine whether trypanosomes lacking
any of these potential RMI1 homologues phenocopy Tbtopo3a’s
growth defect, we constructed mutants lacking Tb927.3.1830
(Figure 1B) or Tb927.8.2040. Wild type, heterozygous and
homozygous mutants were examined for cell growth. Deletion of
Tb927.3.1830 mimicked Tbtopo3a,e x h i b i t i n gam i n o rg r o w t h
defect (Figure 1C), while Tb927.8.2040 deletion grew normally
(data not shown), indicating that Tb927.3.1830 could be a RMI1
homologue but Tb927.8.2040 is probably not. Similar to
Tbtopo3a mutant [39], Tb927.3.1830 deletion shows sensitivity
to hydroxyurea, a drug that blocks replication (data not shown).
Human RMI core complex contains three OB domains, N-
terminal OB1 and C-terminal OB2 in RMI1, and OB3 in RMI2
(Figure 1D). The OB1 of hRMI1 interacts with TOPO3a-BLM to
form the BTB complex and the OB2 with OB3 of RMI2 to form
the RMI subcomplex [22,40]. X-ray crystal structure studies have
shown that the RMI core complex interaction is essential for its in
vivo function [40,41]. The OB1 domain is essential for stimulation
of the dHJ dissolution activity of the BLM-TOPO3a [40]. K166
(green box in Figure 1A) appears to be important for the stability
of OB1 structure of hRMI1 [40]. rmi1-K166A mutant is unable to
interact with TOPO3a and defective in stimulating the dissolution
activity of BLM-TOPO3a [38]. This lysine residue seems to be
conserved in T. brucei Tb927.3.1830 (K157 in green box in
Figure 1A). But Tb927.3.1830 appears to lack OB2 domain and it
is unknown whether there are multiple RMI proteins present in
T. brucei.
Tb927.3.1830 interacts with TbTOPO3a
To confirm whether Tb927.3.1830 is a T. brucei RMI1 homologue,
we performed co-immunoprecipitation experiments in cells expressing
endogenous copies of Tb927.3.1830-3xHA or Tb927.8.2040-3xHA,
and/or TOPO3a-3xMYC, each tagged at the C-terminus, using a
PCR method [42]. The functionalities of TOPO3a-3xMYC and
Tb927.3.1830-3xHA were confirmed by complementation of growth
defects (data not shown). The functionality of Tb927.8.2040-3xHA
could not be assessed as the mutant showed no phenotype but the
tagging was made in a Tb927.8.2040 heterozygote and these grew
normally. Lysates were prepared and immunoprecipitated with either
anti-HA or anti-MYC antibodies. Precipitated proteins were analyzed
by western blot. TOPO3a-3xMYC was pulled down only in
Tb927.3.1830-3xHA immunoprecipitates, but not in Tb927.8.2040-
3xHA (Figure 2A, red box). Consistent with this, TOPO3a-MYC
coimmunoprecipitated with Tb927.3.1830, but not Tb927.8.2040
(Figure 2B, red box). These data confirm that Tb927.3.1830 is a RMI1
homologue, so Tb927.3.1830 will be referred to as TbRMI1
henceforth.
TbRMI1 deficiency increases VSG switching frequency
Deletion of TbTOPO3a caused significant increase (10–40-fold)
in VSG switching frequency [39]. Switching frequency should
increase in the absence of TbRMI1, if TbRMI1 works together
with TbTOPO3a in antigenic switching. We measured the VSG
switching frequency in Tbrmi1 null mutant, using the assay
developed previously [39]. The active expression site, ES1-VSG
427-2 (VSG 221), was doubly marked with a blasticidin-resistance
gene (BSD) and a PUR-TK, immediately downstream of the
promoter and at the 39 end of the 70-bp repeats, respectively
(Figure 3A). VSG switching concurs with the loss or transcriptional
repression of PUR-TK marker, so switched variants can be
counter-selected in media containing ganciclovir (GCV), a
nucleoside analogue that kills TK-expressing cells.
Wild type and rmi1 strains were grown in media containing
blasticidin and puromycin to maintain the homogeneity of the
expressed VSG. The cells were then allowed to switch in the absence
of selection for 3 days. 5610
5 or 1610
6 cells were suspended in
media containing 5 mg/ml GCV and distributed in 96-well plates.
Genuine switchers will be sensitive to puromycin. GCV-resistant
clones that were not switched but carried mutations in TK were
ruled out by examining puromycin sensitivity. GCV
R PUR
S clones
that were not switched and carried mutation(s) in PUR-TK should
still express VSG 427-2. These were excluded by western blot using
antibody against VSG 427-2. Five and three independent cultures
from wild-type and rmi1 mutants, respectively, were examined and
Figure 2. Tb927.3.1830 interacts with TbTOPO3a. (A)
Tb927.3.1830-HA co-immunoprecipitates with TOPO3a-MYC. (B) TO-
PO3a-MYC co-immunoprecipitates with Tb927.3.1830-HA. TOPO3a was
endogenously tagged with 3xMYC, and Tb927.8.2040 and Tb927.3.1830
with 3xHA. Cell lysates were immunoprecipitated either with anti-HA or
anti-MYC antibodies and analyzed by western blot. (*) and (**) indicate
antibody heavy and light chains. Arrow heads indicate break-down
products of 1830-HA.
doi:10.1371/journal.pone.0025313.g002
RMI1 Is Required for T. brucei Antigenic Variation
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e25313the ratio of GCV
R switchers to the total number of cells plated was
plotted in Figure 3B. The results are also summarized in Table 1.
Switching frequency increased , 4 fold in rmi1 (11.063.4610
25),
compared to wild type (2.860.5610
25). To confirm that the
switching phenotype was caused by the absence of RMI1, an empty
vector or a vector containing wild type RMI1 were introduced into
the rmi1 null mutant, and three independent clones from each
transfection were examined for VSG switching frequency. As shown
in Figure 3B, reintroduction of wild-type RMI1 complemented the
increased-switching phenotype of rmi1 (1.860.7610
25), while
empty-vector transfected rmi1 cells still switched at a higher
frequency (20.067.2610
25), indicating that increased-switching
phenotype was due to RMI1 deficiency.
TbRMI1 monitors VSG recombination, similarly to
TbTOPO3a
Hyper-recombination and elevated crossover are prominent
phenotypes caused by TOPO3a deficiency in T. brucei [39]
and in other organisms [26,30,31,43,44]. To determine whether
TbRMI1 is required to suppress VSG GC and crossover, 275
cloned switchers (112 from five wild type cultures and 163 from
three rmi1 cultures) were examined. The diagram in Figure 3A
illustrates four major switching mechanisms characterized. Each
event can be distinguished by assessing blasticidin sensitivity, and
BSD and VSG 427-2 presence by PCR. As summarized in Figure 4
and Table 1, VSG GC and crossover rates increased , 13- and ,
14-fold in the absence of RMI1, compared to wild type.
Figure 3. TbRMI1 deficiency increases VSG switching frequency. (A) VSG switching reporter cell line and switching mechanisms. The active
expression site, ES1-VSG 427-2, was doubly marked with BSD at the promoter and PUR-TK immediately at the 39 end of the 70-bp repeats. VSG
switching events will accompany either loss or repression of the PUR-TK marker, which allows only the switchers to grow in the presence of GCV [39].
Non-switchers can be eliminated as described in the text. Black circles are telomere repeats. (B) TbRMI1 deficiency increases VSG switching frequency.
Switching frequency was measured in wild type, rmi1, and rmi1 cells transfected either with an empty vector or the wild-type RMI1.
doi:10.1371/journal.pone.0025313.g003
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be distinguished, because these switchers will be negative for BSD
and VSG 427-2 when examined by PCR [39]. Frequent loss of
entire active ES was observed when TK was targeted next to the
active ES promoter [45]. Therefore, BSD
- VSG 427-2
- switchers
should represent either ES GC or ES loss (could be associated with
multiple events). Deletion of RMI1 decreased the rate of ‘ES GC
or ES loss’, indicating that RMI1 is required for ES GC, a gene
conversion event that could span ,50 kb. Collectively, we
conclude that RMI1 also controls the outcome of recombinational
switching near VSGs, similarly to TOPO3a, and that RMI1
functions together with TOPO3a in T. brucei antigenic variation.
Our data suggest that the RMI1-TOPO3a pathway has two
distinct effects on VSG switching, suppressing recombination near
the VSG but promoting recombination near the ES promoter.
Genetic interaction between TbRMI1 and TbTOPO3a
Although TbRMI1 interacts with TbTOPO3a and the rmi1 null
mutation caused similar outcomes of VSG switching as the topo3a,
RMI1 deficiency increased VSG switching frequency by only , 4-
fold, which is less than previously reported for TOPO3a deficiency
[39]. If TOPO3a-RMI1 works in the same pathway, the rmi1 topo3a
double mutant should exhibit the same phenotype as one of the
single mutants. If rmi1 topo3a exhibits an additive phenotype, it is
possible that they play additional separate roles. To determine the
genetic relationship between RMI1 and TOPO3a, we compared
the switching frequencies of wild type, rmi1, topo3a
, and rmi1 topo3a
double mutant. Switching was significantly increased in the topo3a
single mutant (53.2623.1610
25), , 10–30-fold higher than wild
type (2.860.5610
25), and this was , 5-fold higher than Tbrmi1
(11.063.4610
25) (Figure 5A). The double mutant behaved more
like rmi1 single mutant, exhibiting only , 2–3-fold increase
(6.561.3610
25) relative to wild type, suggesting that RMI1 is
epistatictoTOPO3ainantigenicswitching.Inthermi1topo3adouble
mutant, as summarized in Table 1, VSG switching also occurred
mainly by VSG GC and crossover.
Next, we examined whether Tbrmi1 causes hyper-recombina-
tion elsewhere and whether RMI1 is also epistatic to TOPO3a in
this context. Previously, by replacing one allele of TbURA3 with
HYG-TK, we devised a recombination assay [39] in which GC at a
non-ES locus can be measured using two counter-selecting drugs:
GCV that kills TK
+ cells and 5-FOA that kills URA3
+. The
frequency of GCV
R and FOA
R represents the GC rate at the URA3
locus. Using this assay, GC increased by 5.9-fold in the absence of
Table 1. VSG-switching events in wild type, rmi1, rad51, rmi1 rad51, and rmi1 topo3a cultures.
Genotype Total # cells plated Number of switchers
Total VSG GC XO ‘ES GC or loss’ In situ ES+XO
WT 500,000 17 3 3 11 0 0
WT 500,000 11 5 0 6 0 0
WT 1,000,000 26 4 0 20 1 1
WT 1,000,000 26 9 0 16 1 0
WT 1,000,000 31 6 2 23 0 0
rmi1 500,000 74 56 16 2 0 0
rmi1 478,000 39 29 10 0 0 0
rmi1 500,000 50 34 14 2 0 0
rad51 2,000,000 39 30 4 2 3 0
rad51 2,000,000 26 9 4 1 9 3
rad51 2,000,000 10 7 1 1 0 1
rmi1 rad51 2,000,000 4 0 2 1 1 0
rmi1 rad51 2,000,000 2 0 1 0 1 0
rmi1 rad51 2,000,000 3 2 1 0 0 0
rmi1 topo3a 500,000 28 22 6 0 0 0
rmi1 topo3a 500,000 37 21 13 2 0 1
doi:10.1371/journal.pone.0025313.t001
Figure 4. TbRMI1 monitors VSG recombination. TbRMI1 deficien-
cy increases VSG GC and crossover (XO) but decreases ES GC. 275
cloned switchers were examined and the frequency of each switching
mechanism was plotted. White bars are wild type and dark grey bars are
rmi1 mutant. Error bars indicate standard deviation. The results are also
summarized in Table 1. Switched variants were assigned as follows
(Figure 3A diagram); VSG-GC switchers, BSD
+ VSG 427-2
-; ‘ES GC or ES
loss’ switchers, BSD
- VSG 427-2
-; crossover switchers, BSD
+ VSG 427-2
+; in
situ, BSD
+ VSG 427-2
+.
doi:10.1371/journal.pone.0025313.g004
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wild type, rmi1 or rmi1 topo3a strains. Three independent HYG
R
clones each were examined and fold increase relative to wild type
was plotted (Figure 5B). RMI1 deficiency increased GC rate (2.9-
fold), and the double mutant behaved more like rmi1 single
mutant, exhibiting 2.4-fold increase of GC. The data show that
RMI1 is epistatic to TOPO3a in gene conversion at theURA3 locus
and in VSG switching.
TbRMI1 is required for both RAD51-dependent and
RAD51-independent VSG switching
The increased-switching phenotype of Tbtopo3a was dependent
on TbRAD51 [39]. Therefore, we asked whether RAD51 is
required for the increased switching observed in the rmi1 mutant.
Both alleles of RAD51 were deleted in wild type and rmi1 mutant.
rad51 single and rmi1 rad51 double mutants were examined for
VSG switching frequency and mechanisms. 2610
6 cells from three
independent cultures of each mutant were plated, and cloned
GCV
R switchers were analyzed. Deletion of RAD51 caused only 2-
fold reduction in overall VSG-switching in the presence of RMI1.
On the other hand, it caused , 19-fold reduction in the absence
of RMI1, compared to wild type (Figure 6A and Table 1). This
suggests that there are at least two recombination pathways
working in antigenic switching mechanisms: RAD51-dependent
and -independent.
75 and 10 cloned switchers were analyzed from rad51 and rmi1
rad51 mutants, respectively (Figure 6B, C, and D and Table 1).
VSG GC was not affected in rad51, but it was significantly reduced
in rad51 rmi1 double mutants, indicating that at least two pathways
are operating for VSG GC, one of which requires RMI1
independently of RAD51. RAD51 deletion eliminated the
increased VSG GC and crossover phenotype of rmi1, suggesting
that RMI1 may be required to suppress RAD51-dependent
recombinogenic structures arising between the active VSG and
VSG donors, similar to the genetic interaction between TOPO3a
and RAD51. Unlike VSG GC, ‘ES GC or ES loss’ was reduced in
an rmi1 or rad51 single mutant, suggesting that RAD51-dependent
recombinogenic structure may not be the cause of this switching
mechanism. Therefore, recombination near ES promoter is
fundamentally different from that near VSG. Collectively, we
propose that RMI1 is required to suppress RAD51-dependent
recombination intermediates near VSG, but it is required to
promote recombination near ES promoter.
Discussion
Extensive genetic and biochemical studies from yeasts have
established the mechanisms of several key recombination path-
ways. These pathways serve multiple purposes, depending on
cellular needs. Choice of recombination pathways determines cell
fate. Failure to make the right choices can result in chromosome
instability and/or in incompetence in responding to the environ-
ment, both eventually leading to high chance of lethality.
T. brucei expresses one type of VSG gene at a time, with the
potential to express countless different VSGs. Switching to a
different VSG allows parasites to escape a host’s immune
responses. As illustrated in Figure 3A, recombination-mediated
VSG switching can be initiated near or downstream of the ES
promoter. An entire silent ES or a relatively smaller region
containing a silent VSG can be duplicated and transposed into the
active ES to replace a previously active ES-associated VSG. This
appears to occur through break-induced replication (BIR) [46],
which is at least partly due to the 70-bp repeats that are present
upstream of VSG genes, but limited homologies are present within
and downstream of VSG genes. Telomere repeats may facilitate
VSG switching, providing a second region of homology, but this
possibility has not been extensively examined. How the recombi-
nation-mediated VSG switching occurs is still not clear.
Similar to mitotic recombination, crossover is relatively
infrequent in recombination-mediated VSG switching [13-16,39].
The RTR complex is one of the major factors that control mitotic
crossover in other organisms. The RTR complex consists of a
RecQ-family helicase (BLM/SGS1), a Topoisomerase III a, and
RMI1/2 (BLAP75/18) [17-23]. In vitro studies showed that human
hRMI1 stimulates the dHJ dissolution activity of TOPO3a and
the dHJ unwinding activity of BLM-TOPO3a [35,36].
Figure 5. Genetic interaction between T. brucei RMI1 and
TOPO3a. (A) TbRMI1 is epistatic to TbTOPO3a in VSG switching. (B)
RMI1 absence increases gene-conversion frequency at URA3 locus and
TbRMI1 is epistatic to TbTOPO3a in gene conversion at this locus. Two
counter-selectable markers, TK and URA3, were used to measure the GC
rates [39]. GCV
R and FOA
R clones were counted and fold increase
relative to wild type was plotted. Error bars indicate standard deviation.
(*) in Figure 5B indicates topo3a data taken from the previous report
[39]. Unpaired T tests were done and means of switching and GC
frequencies were significantly different in the mutants.
doi:10.1371/journal.pone.0025313.g005
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PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e25313We have previously shown that TOPO3a deficiency is
associated with hyper-recombination, consistent with studies in
other organisms, and with hyper-VSG switching phenotypes in
T. brucei [39]. TOPO3a is required to suppress crossover VSG
switching in T. brucei. In this study, we characterized a T. brucei
RMI1 ortholog that physically interacts with TbTOPO3a. Similar
to TOPO3a, deficiency of TbRMI1 increased the rate of VSG
crossover, a hallmark of defects in RTR complex function. In
addition, TbRMI1 deficiency increased VSG GC switching to a
similar extent as TbTOPO3a deficiency, which caused dramatic
increase in VSG GC rate. VSG GC was around 70% in both wild
type and Tbtopo3a mutant, indicating that VSG GC frequency was
10-40 fold higher than wild type, as the overall VSG switching
frequency was 10-40 fold higher in the Tbtopo3a mutant [39]. One
of major functions of the RTR complex is to control recombina-
tion intermediates accumulating during replication stress. Genetic
studies from budding yeast demonstrated that the growth defect of
top3 is caused by the accumulation of recombination intermediates
and that the defect could be relieved by mutations in SGS1 and in
the RAD51-pathway [28,32,33]. Recombination intermediates
accumulated when TOP3 enzyme activity was compromised
[34]. Our data from this study suggests that RMI1 works together
with TOPO3a during VSG switching. We propose that accumu-
lation of recombination intermediates near the active VSG causes
hyper-VSG GC and hyper-crossover phenotypes when TOPO3a-
RMI1 function is compromised (Figure 7 and [39]).
What could cause recombination intermediates to accumulate
in the active VSG locus? Genome-wide analysis of ORC1
association showed that ORC1 was enriched at subtelomeric
regions (Kinetoplastid Molecular Cell Biology meeting April 2011,
Tiengwe CM et al.). Some of these ORC1 binding sites may
initiate replication. VSGs are located close to telomere repeats. It
was shown that the telomere repeats are fragile in mammalian
cells, dependent on replication and telomere binding factor TRF1
[47]. In the absence of TRF1, telomere repeats break more
frequently and replication was frequently initiated within the
TTAGGG repeats, increasing telomere instability and sister-
chromatid bridging. Interestingly, BLM and RTEL helicases were
required to suppress the telomere fragility. Thus, it is possible that
fragility of the active ES could be due to a combination of telomere
instability and replication defects. In the absence of TOPO3a or
RMI1, these could cause the accumulation of recombination
intermediates.
Due to lack of information on DNA replication in T. brucei,i ti s
impossible to determine the identities of recombination interme-
diates that might accumulate in topo3a or rmi1 trypanosome
mutants. Recombination intermediates could arise when replica-
tion forks encounter DNA damage, during replication progression
Figure 6. TbRMI1 is required for both RAD51-dependent and RAD51-independent VSG switching. (A) Simultaneous deletion of RMI1 and
RAD51 severely impairs VSG switching. Overall VSG switching frequencies of wild type, rmi1, rad51, and rmi1 rad51 were plotted. (B) Increased VSG GC
rate in rmi1 was dependent on RAD51, but RMI1 also functions in VSG GC switching independently of RAD51. (C) Increased crossover in rmi1 was
dependent on RAD51. (D) ‘ES GC or ES loss’ switching was impaired in a rad51 or rmi1 single mutant. The results are also summarized in Table 1.
doi:10.1371/journal.pone.0025313.g006
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with entangled regions, called hemicatenanes, which can be
processed to ‘rec-X’ structures, whose resolution requires SGS1-
TOP3 in budding yeast [34,48,49]. These structures are different
in regard to base pairing and presence of single stranded regions
and they can be visualized by DNA 2D gel analysis by Southern
blot, a technique unavailable in T. brucei. We showed that VSG GC
and crossover are suppressed by TOPO3a and RMI1 in a
RAD51-dependent manner. Therefore, we think that TOPO3a-
RMI1 may play roles in maintaining ES integrity near VSGsb y
removing these ‘unwanted’ recombination intermediates. Without
TOPO3a-RMI1, they might be resolved by other nucleases
(crossover), or a silent VSG locus might be used as a new template
during hemicatenane-mediated template switching using its
homology sequences and complete replication (VSG GC). It is
possible that TOPO3a-RMI1 deficiency could be associated with
location specific VSG switching phenotypes due to replication
stability ‘at risk’ zone(s) near VSG genes. In the normal situation,
TOPO3a-RMI1 may be responsible for protecting the integrity of
that region(s) (Figure 7(a)).
When double strand breaks (DSBs) occur, broken DNA ends
are resected, leaving a 39 overhang, and a RAD51 filament on
single stranded DNA invades a template strand to form a D-loop.
How this structure is processed can decide how the breaks are
repaired. End resection requires SGS1-DNA2-RPA, and EXO1,
and SAE2-MRE11 complex and the end resection activity of
SGS1 is stimulated by TOP3-RMI1 in budding yeast [50,51]. BIR
frequency increases 39-fold in sgs1D exo1D double mutants [52].
Interestingly, in combination with exo1D, BIR was increased in a
separation-of-function allele of SGS1, sgs1-D664D, which is
proficient for gene conversion but defective for resolution of
recombinogenic X-structures formed by replication fork stalling
[52,53]. The residue D664 is located at the second acidic region
(AR2) in the N-terminus of SGS1 and the sgs1-AR2D shows similar
phenotype as the sgs1-D664D. There are two recQ family helicases
in T. brucei, Tb927.8.6690 and Tb927.6.3580, and Tb927.8.6690
appears to be a BLM/SGS1 ortholog. The region encompassing
D664 of SGS1 seems to be conserved in Tb927.8.6690;
YPWSD664E in SGS1 and YPWSE449E in Tb927.8.6690.
Tb927.8.6690 and mutations at this particular region would be
useful tools to study molecular mechanism of VSG switching more
in detail in the future.
It is notable that VSG GC frequency decreased further in rmi1
rad51 double mutants compared to wild type, suggesting that there
are pathways that require RMI1, independently of RAD51. Studies
in yeasts and in T. brucei have shown that recombination still
occurs in rad51D cells [54-56]. In the absence of telomerase,
telomeres are maintained by a RAD51-dependent and indepen-
dent pathways [57-59]. It is possible that RMI1 may play distinct
roles in VSG switching in a RAD51-independent manner.
The frequency of ‘ES GC or ES loss’ decreased in the absence
of RMI1 or RAD51, unlike VSG GC, which was significantly
increased in the absence of RMI1 and was not affected by RAD51.
This is interesting but puzzling, considering that hyper-recombi-
nation is the hallmark phenotype of RMI1 deficiency. ‘ES GC or
ES loss’ switching seems to occur in a RAD51 and/or RMI1
dependent manner, but their genetic relations cannot be deduced
from the current data. However, it is clear that ES GC is not
triggered by the same source as the VSG GC. Random breaks may
occur at the active promoter due to high level of transcription and
these breaks would normally be repaired by homologous
recombination, using sister-chromatids, or by NHEJ. However,
infrequently, template switching (to a silent ES promoter region)
could occur and be repaired by BIR to generate ES GC switchers.
When BIR was assayed in a budding yeast cell line with two
template chromosomes available, template switching occurred
about 20 percent of the time, usually near the sites of strand
invasion [60]. The current hypothesis is that repair could be
completed by D-loop migration coupled with lagging strand DNA
synthesis moving along the template or strand invasion interme-
diates can be cleaved by endonuclease(s) [60,61]. This cleavage
would allow a new replication fork to establish between two
chromosomes (the active and a silent ES in the case of VSG
switching). As ES GC switching requires duplication of much
larger fragment (, 50 kb) than the VSG GC (, 4 kb), establishing
a stable replication fork could be more advantageous than a
migrating D-loop for ES GC, while it would not matter for VSG
GC events that require duplication of shorter regions. The repair
can be completed by a newly assembled replication fork between
the active and silent ES, giving rise to an ES GC switcher (Figure 7
(b)).
Figure 7. Multiple genetic networks in recombination-mediat-
ed VSG variation. The diagram shows the active ES (ES1) expressing
VSG (red) and a silent ES containing vsg (green). RMI1 deficiency
exhibited opposite phenotype in VSG-GC and ES GC switching,
suggesting that molecular mechanisms of these events are distinct.
We propose that there may be ‘replication fork instability zone(s)’ near
VSG, potentially the 70-bp repeats, but not in ES promoter region. The
RMI1-TOPO3a is required to dissolve recombination intermediates
arising in this zone during replication. When their function is
compromised, recombination intermediates accumulate and result in
VSG-GC and crossover switches (a). RMI1 is required to promote ES GC.
As ES GC requires extension of much longer regions compared to VSG
GC, having a stable replication fork must be advantageous than having
a migrating D-loop. Budding yeast SGS1 is required for replisome
stability. Therefore, we propose that T. brucei RMI1-TOPO3a might
stabilize a newly assembled replication fork between the active and a
silent ES near promoter region. Formation of a stable replication fork
may be the key step to generate ES GC switching (b).
doi:10.1371/journal.pone.0025313.g007
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assembly of replication factors at the fork, in collaboration with
checkpoint kinase MEC1 [62]. Therefore, TbRMI1-TOPO3a
might be required for the stability of a newly formed replication
fork between the active and a silent ES promoter region. If this is
the case, generation of ES GC switching should require RAD51
and RMI1-TOPO3a functions. Alternatively, RMI1 might have
novel function in the context of ES promoter, which may
indirectly affect RAD51-dependent BIR. Transcription of ES
occurs polycistronically with a VSG located , 50 kb downstream
of the promoter, the only site where transcription machinery
assembles within the unit. ES GC and VSG GC occur in different
chromatin environments, so the mechanisms of these gene
conversions could be fundamentally distinct.
The rmi1 mutant was epistatic to topo3a in VSG switching
phenotype. This genetic interaction is interesting because one
would expect the opposite scenario considering that TOPO3a
possesses enzymatic activity for resolution of recombination
intermediates, which is stimulated by RMI1 [35,36]. The epistatic
interaction of TbRMI1 and TbTOPO3a in VSG switching
suggests that TbRMI1 may have a role, potentially with BLM
helicase, in a process upstream of TbTOPO3a.
Given high level of sequence similarities between ESs, it is likely
that silent ESs can recombine at a certain rate and yet the ES
structures seem to be well maintained, suggesting that silent ES
recombination may also be suppressed by protectors of genome
integrity, and recombination of silent ESs might be elevated in
topo3a or rmi1 trypanosome mutants. It is difficult to examine
recombination rates at or between silent ESs quantitatively, due to
technical difficulties, such as strong gene silencing and sequence
similarities.
Table 2. Strains used in this study.
Names (sources) Genotypes Manipulations
SM WT T7 RNA polymerase and Tet repressor (TetR):: NEO
HSTB-188 [39] WT ES1 promoter::BSD
HSTB-261 [39] WT ES1 promoter::BSD, 70-bp repeats-PUR-TK
HSTB-229 rmi1
-/+ ES1 promoter::BSD, rmi1DloxP-HYG-TK-loxP/+
HSTB-286 rmi1
-/- ES1 promoter::BSD, rmi1DloxP-HYG-TK-loxP/DloxP-PUR-loxP
HSTB-298 rmi1
-/- ES1 promoter::BSD, rmi1DloxP/DloxP
HSTB-336 rmi1
-/- ES1 promoter::BSD, 70-bp repeats-PUR-TK, rmi1DloxP/DloxP
HSTB-411, 412, 413 rmi1
-/- + Vector ES1 promoter::BSD, 70-bp repeats-PUR-TK, rmi1DloxP/DloxP
+ pHD309 (empty vector)
HSTB-414, 415, 416 rmi1
-/- + RMI1-wt ES1 promoter::BSD, 70-bp repeats-PUR-TK, rmi1DloxP/DloxP
+ pSY38 (RMI1-wt in pHD309)
HSTB-344 [39] topo3a
-/- ES1 promoter::BSD, 70-bp repeats-PUR-TK, topo3aDloxP/DloxP
HSTB-365 [39] rad51
-/- ES1 promoter::BSD, 70-bp repeats-PUR-TK, rad51DHYG/rad51DPHELO
HSTB-384, 385, 386 rmi1
-/- rad51
-/- ES1 promoter::BSD, 70-bp repeats-PUR-TK, rmi1DloxP/DloxP,
rad51DHYG/rad51DPHELO
HSTB-456 rmi1
-/- topo3a
-/- ES1 promoter::BSD, 70-bp repeats-PUR-TK, rmi1DloxP/DloxP, topo3aDloxP/DloxP
HSTB-201 2040-3HA(*) 2040-3HA::HYG
HSTB-210 RMI1-3HA RMI1-3HA::PUR
HSTB-213 TOPO3a-3MYC TOPO3a-3MYC::PHLEO
HSTB-218 2040-3HA(*) TOPO3a-3MYC 2040-3HA::HYG, TOPO3a-3MYC::PHLEO
HSTB-222 RMI1-3HA TOPO3a-3MYC RMI1-3HA::PUR, TOPO3a-3MYC::PHLEO
(*) The full annotation is Tb927.8.2040.
doi:10.1371/journal.pone.0025313.t002
Table 3. Plasmids used in this study.
Names Inserts, targeting loci, and markers Sources
pHD309 Vector to target at TUB array, HYG
pLHTL-pyrFE TbURA3::HYG-TK [64]
pLEW100-Cre Cre-recombinase in expression
vector, PHLEO
[64]
pHJ17 loxP-HYG-TK-loxP [39]
pHJ18 loxP-PUR-TK-loxP [39]
pHJ23 To target BSD downstream of
ES promoter
[39]
pHJ63 TOPO3aD ::loxP-PUR-TK-loxP [39]
pHJ64 TOPO3aD ::loxP-HYG-TK-loxP [39]
pSY1 RAD51D::HYG [39]
pSY23 RAD51D::PHLEO [39]
pHJ71 RMI1D::loxP-HYG-TK-loxP This study
pHJ77 RMI1D:: loxP-PUR-loxP This study
pSY38 To insert wild-type RMI1 at TUB
array, HYG
This study
pMOTag53M One-step PCR-3xMYC tagging
construct, PHLEO
[42]
pMOTag4H One-step PCR-3xHA tagging
construct, HYG
[42]
pMOTag2H One-step PCR-3xHA tagging
construct, PUR
[42]
doi:10.1371/journal.pone.0025313.t003
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although VSG switching is essential for parasite survival in the host
and VSG GC is a dominant immune evasion mechanism. During
host infection, parasite numbers rise and fall periodically. We think
that recombination-mediated VSG switching is generally sup-
pressed but one or two silent VSG loci may have a higher chance to
recombine with the active ES, potentially due to their proximity.
VSG loci might be highly recombinogenic without this suppression,
which could increase the possibility for parasites to use up their
expressible VSGs at the early stage of infection, consequently
resulting in eradication by host immunity. To prevent this,
parasites may expose their ES-linked VSG repertoire gradually to
preserve the population survival by VSG switching and to prolong
their infection, while having some time to accumulate novel VSGs
at transcribable loci.
VSG switching requires key factors in recombination and
replication and their interplay controls the outcome of VSG
switches. Although it is beginning to reveal its mystery, the control
mechanism of antigenic switching must involve various cellular
processes, whose contributions are largely unknown. Additional
factors as well as specific alleles of the RTR complex members
should be studied thoroughly to understand mechanism of
antigenic variation in depth.
Materials and Methods
Trypanosome strains and plasmids
Trypanosoma brucei bloodstream forms (strain Lister 427 antigenic
type MITat1.2 clone 221a (expressing VSG 427-2)) were cultured
in HMI-9 at 37uC. The cell lines constructed for this study are
listed in Table 2. They are of ‘single marker (SM)’ background that
expresses T7 RNA polymerase and Tet repressor [63]. Stable
clones were obtained and maintained in HMI-9 media containing
necessary antibiotics at the following concentrations, unless
otherwise stated: 2.5 mg/ml, G418 (Sigma); 5 mg/ml, blasticidin
(Invivogen); 5 mg/ml, hygromycin (Sigma); 0.1 mg/ml, puromycin
(Sigma); 1 mg/ml, phleomycin (Invivogen). Plasmids used for this
study are listed in Table 3.
Construction of Tbrmi1 knock-out lines
To generate T. brucei rmi1 mutants, HSTB-188, a wild-type
‘single marker’ line with the active ES marked with a blasticidin-
resistance gene (BSD), was sequentially transfected with deletion
cassettes. The cassettes contain either a hygromycin-resistance
gene conjugated with a Herpes simplex virus thymidine kinase (HYG-
TK) or a puromycin-resistance gene (PUR) flanked by homology
sequences to upstream and downstream of Tb927.3.1830.
Deletions were confirmed by PCR analyses. Single knock-out
(sKO), rmi1
-/+, and double KO, rmi1
-/- were used to assess growth
phenotypes, as described previously [39]. Selection markers
flanked by loxP sites were removed by transiently expressing
Cre-recombinase (pLew100-Cre). The cells that lost both HYG-TK
and PUR were selected in 50 mg/ml ganciclovir (GCV). Loss of
markers was confirmed by resistance to puromycin and hygro-
mycin, and by PCR analysis. The sequences of primers used here
are available upon request. These cell lines were used for
recombination and VSG switching assays.
Co-immunoprecipitation and western blot
About 10
8 cells were lysed in lysis buffer (25 mM Tris–HCl
(pH 7.5), 1 mM EDTA, 0.5% NP-40, 10% glycerol, 1 mM
phenylmethylsulfonylfloride (PMSF), 1 mM dithiothreitol (DTT),
protease inhibitor cocktails (Sigma)). Whole cell lysates were
immunoprecipitated with rabbit anti-HA or anti-MYC antibodies.
Immunoprecipitates were analyzed by western blot using mouse
anti-HA or anti-MYC antibodies.
VSG switching assay and analyses of switchers
To create switching reporter strains, the promoter and 70-bp
repeats of the active ES were marked with BSD and PUR-TK,
respectively, as described previously [39]. To determine VSG
switching frequency and mechanisms, cells were maintained in the
presence of blasticidin and puromycin to exclude switchers from
the starting population. Cells were then allowed to switch in the
absence of drug selection for 3 days. Indicated numbers of cells
(Table 1) were suspended in HMI-9 media containing 5–10 mg/ml
GCV and distributed in 96-well plates. GCV-resistant clones were
examined for sensitivity to 2 mg/ml puromycin, to exclude non-
switchers that carry spontaneous mutation(s) in TK but not in PUR
gene. Non-switchers that carry mutations both in PUR and TK
were ruled out by western blot analysis using anti-VSG 427-2
antibodies. Cloned switchers were analyzed for blasticidin
sensitivity. Genomic DNA was analyzed by PCR for the presence
of BSD and VSG 427-2. The sequences of primers used here are
available upon request.
It is noted that all VSG switching assays in this study were
performed without the MACS-enrichment step. MACS step may
have reduced the number of some switchers, as ‘ES GC or ES loss’
switchers appear to have growth disadvantages, compared to
parental cells and VSG GC switchers.
Recombination assay
Gene-conversion frequency at TbURA3 locus was determined as
described previously [39].
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